spacer
home > ebr > winter 2002 > realising the potential of human cells for therapy
PUBLICATIONS
European Biopharmaceutical Review

Realising the Potential of Human Cells for Therapy

Cell therapy offers the potential to revolutionise health care. Instead of taking medicines that address only the symptoms of chronic disease, cell implants and engineered tissues will be able to cure a broad range of health conditions. The potential returns, both in terms of clinical benefit and financial reward, are significant. Not only can cell therapies displace expensive medicines, they can also greatly reduce the costs of supporting patients on long-term medical regimes. This is not a theoretical proposition - cell and cell-derived therapies are already being used effectively for a variety of applications.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Dr Will West, Product Development Director at CellFactors Dr Will West is Product Development Director at CellFactors plc, where his main focus has been on developing and commercialising SkeletexTM, a human cell-derived matrix that induces bone formation.
His scientific background is in immunology, virology and cell culture, and he completed his PhD, sponsored by Unilever (UniPath), in 1992. Following this, Dr West held a post-doctoral position at the National Institute of Biological Standards and Control, working on HIV vaccines and MHC proteins. Dr West subsequently worked at Procter & Gamble, responsible for product and claims development in a number of health care therapeutic areas. He has an MBA from London Business School.

spacer
Dr Will West
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing steadily.

According to the international air cargo information provider WACD's September data, the global air cargo brand Turkish Cargo, which serves 126 countries of the world, grew significantly by achieving a tonnage increase of 8.8 percent in a sector wherein the global air cargo market shrank by -5.4 percent.
More info >>

White Papers

RSSL introduces same-day mycoplasma testing service in UK

RSSL

Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical, and biopharmaceutical sectors, has introduced the United Kingdom’s first same-day mycoplasma testing service for manufacturers of biologic medicines.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement